Atorvastatin Inhibits Functional Expression of Proatherogenic TLR2 in Arterial Endothelial Cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cellular Physiology and Biochemistry

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000335758PMID 22178874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in Atherosclerosis

  2012cited by this paper
• Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.

  2011cited by this paper
• Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis

  2009cited by this paper
• Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events

  2008cited by this paper
• Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo.

  2006cited by this paper
• Toll-like receptors and atherosclerosis

  2006cited by this paper
• Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14+ Monocytes

  2005cited by this paper
• Modulation of atherosclerosis in mice by Toll-like receptor 2.

  2005cited by this paper
• Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.R400015-JLR200

  2005cited by this paper
• Simvastatin Prevents Vascular Hyporeactivity During Inflammation

  2004cited by this paper
• Simvastatin Prevents Vascular Hyporeactivity During Inflammation

  2004cited by this paper
• Role of Toll-like receptors in atherosclerosis.

  2004cited by this paper
• Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling

  2004cited by this paper
• Innate Immune Recognition of Invasive Bacteria Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice

  2004cited by this paper
• Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

  2004cited by this paper
• Flow-Dependent Regulation of Endothelial Toll-Like Receptor 2 Expression Through Inhibition of SP1 Activity

  2004cited by this paper
• Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

  2004cited by this paper
• Low-Level Endotoxin Induces Potent Inflammatory Activation of Human Blood Vessels: Inhibition by Statins

  2003cited by this paper
• Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.

  2003cited by this paper
• Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation

  2002cited by this paper
• Transcriptional Regulation of the Human Toll-Like Receptor 2 Gene in Monocytes and Macrophages1

  2002cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Toll-like receptors and innate immunity

  2001cited by this paper
• Casein Kinase II-mediated Phosphorylation of the C Terminus of Sp1 Decreases Its DNA Binding Activity*

  1997cited by this paper
• Isolation, Structure Elucidation, and Synthesis of a Macrophage Stimulatory Lipopeptide from Mycoplasma fermentans Acting at Picomolar Concentration

  1997cited by this paper
• Platelet-activating Factor Induces NF-κB Activation through a G Protein-coupled Pathway (*)

  1995cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Integrating genetic crosstalk between atherosclerosis and lung adenocarcinoma to advance precision diagnosis and treatment

  2025cites this paper
• Role of post-translational modifications of Sp1 in cardiovascular diseases

  2024cites this paper
• Targeting the toll-like receptor pathway as a therapeutic strategy for neonatal infection.

  2021cites this paper
• Circulating intermediate monocytes and toll-like receptor 4 correlate with low-voltage zones in atrial fibrillation

  2020cites this paper
• Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques

  2019influential citation
• RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy

  2018cites this paper
• Toll-Like Receptors 2 and 4 Predict New-Onset Atrial Fibrillation in Acute Myocardial Infarction Patients.

  2018cites this paper
• Beyond Cholesterol - New Cardiovascular Biomarkers.

  2016cites this paper
• Next-Generation Nutritional Biomarkers to Guide Better Health Care: 84th Nestlé Nutrition Institute Workshop, Lausanne, September 2014

  2016cites this paper
• Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-кB/ZNF202 pathway in THP-1 macrophages.

  2016cites this paper
• Stiffening-Induced High Pulsatility Flow Activates Endothelial Inflammation via a TLR2/NF-κB Pathway

  2014cites this paper
• Laboratory medicine for molecular imaging of atherosclerosis.

  2014cites this paper
• Toll-Like Receptors in Atherosclerosis

  2013cites this paper
• TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation

  2012cites this paper